CHORUS SEOUL 2017 LAAO LIVE I

Slides:

Advertisements

Similar presentations

ATRIAL FIBRILLATION.

Advertisements

Atrial Fibrillation Service

Delayed Common Post-operative complications occurred after LAAO Dr. Iat-Lon,Leong Department of Medicine, Division of Cardiology Macau Kiang Wu Hospital.

ABC Advanced Bleeding Care Case: Spontaneous Kidney Rupture Santiago Ramón Leal-Noval.

CLINICAL CASES.

Efficacy and Safety of Dabigatran vs. Warfarin in Patients with Atrial Fibrillation - Japanese population in the RE-LY ® - Shinya Goto, MD., PhD. Tokai.

Atrial Fibrillation Stroke Prevention with Oral Anticoagulants Why is there discordance between guideline committees & specialists when the data is based.

Atrial Fibrillation Update 2012 Dr C Seifer Section of Cardiology St Boniface Hospital.

Atrial Fibrillation. Outline Epidemiology Signs and Symptoms Etiology Differential Diagnosis Diagnostic Tests Classification Management.

Atrial Fibrillation Steve McGlynn

Evidence That D-dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Oral Anticoagulant.

APIXABAN NELLA SPAF 21 maggio 2015 ROMA Dott. Sergio Agosti Cardiologo, Ospedale Novi Ligure (AL)

The Long Term Multi-Center Extension of Dabigatran Treatment in Patients with Atrial Fibrillation (RELY-ABLE) study To reviewers and moderators: These.

Atrial Fibrillation Now and Then Min-Yen Han,M.D. November 15,2014.

1 Objectives, design and initial results from Phase I Nils Schoof Corp. Dept. Global Epidemiology, Boehringer Ingelheim GmbH.

 3 million Americans  160,000 new cases each year  16 million by 2050  90% of patients have recurrences  Incremental cost.

Accuracy of CHADS2, CHA2DS2- VASC and HAS-BLED scores in evaluation of stroke and bleeding risk First author: Alexandra Murar Co-author: Andreia Gherasâm.

Treatment of Atrial Fibrillation M Samson – PGY-2 Riverside Campus July 17, 2015 Academic Day.

The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.

Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.

Prevention of thromboembolism in AF ACC/AHA/ESC Guidelines Jin-Bae Kim, MD, PhD Arrhythmia Service, Division of Cardiology Cardiovascular Center, Kyung.

R4 문정락 / IC prof. 김진배 Lancet Haematol 2015;2: e150–59.

Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.

Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Cardiology Division, Jeju National University Hospital, Jeju, KOREA

Repair of a Thoracic Aorta Aneurysm

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Non-valvular Atrial Fibrillation.

You can never be too Thin…. An Update on NOACs

How to Screen Patients for LAAC

Antonelli D, Koren O. Rozner E. Turgeman Y.

Antithrombotic Therapy in Atrial Fibrillation

TAVI „Catch me if you can!“

Efficacy and Safety of Dabigatran vs

Anne Dobbs Lead ACP Emergency Medicine

Presenter: Harish Raj Seetha Rammohan

Volume 28, Issue 6, Pages (December 2012)

Anticoagulation in Atrial Fibrillation

No evidence that AF type significantly impacts stroke risk

A Diagnostic Dilemma of Hypoglycemia in a Non-Diabetic Patient

The Atrial Fibrillation Clinic in Llanelli

Randomized Evaluation of Long-term anticoagulant therapY

Atrial fibrillation (AF) and flutter

Click here for title Click here for subtitle

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

ACTIVE A Effects of Addition of Clopidogrel to Aspirin in Patients with Atrial Fibrillation who are Unsuitable for Vitamin K Antagonists.

ATHENA Trial Presented at Heart Rhythm 2008 in San Francisco, USA

Nat. Rev. Cardiol. doi: /nrcardio

Educational Event 23rd & 24th January 2013

Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.

Assessing the Risk for Stroke in Patients With Atrial Fibrillation

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

What Anticoagulant Registries Are Revealing

Relative Risk of Events by CHA2DS2-VASc Score

Antithrombotic Therapy for Atrial Fibrillation

Study Background and Rationale Updated October 24, 2018

Cancer-Associated Thrombosis

Bridging Anticoagulation

A Real Headache: Anticoagulation and a Subdural Hematoma

Efficacy and safety outcomes with NOAC compared with warfarin in NOAC patients with 14 457 years of risk and 49 418 warfarin patients with 75 747.

Optimizing Atrial Fibrillation Management

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

5 Good Minutes on Atrial Fibrillation-related Stroke

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Forest plot illustrating the risk ratio of any bleeding and GRADE assessment. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI,

Figure 8. Stroke prevention strategy in patients with AF

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

NICE 2014 Check pulse in patients presenting with:

Forest plot illustrating the risk ratio of major bleeding

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Presentation transcript:

CHORUS SEOUL 2017 LAAO LIVE I Persistent Atrial Fibrillation Patient with Alcoholic Liver Cirrhosis and Cerebral Aneurysm Nov. 04. 2017 Chung-Ang University Hospital Cardiovascular & Arrhythmia Center SEOUL, COREE

Brief Case Summary Age / Sex: 71 / Male C/C: Major bleeding during anticoagulation during VKA and Non-major bleeding during Dabigatran 110 mg bid Past medical history # Hypertension # Alcoholic liver cirrhosis (Child A, Platelet 80,000/mL) # s/p L-spine Fx. (NSAIDs) # s/p Renal cell carcinoma (Rt. Partial nephrectomy) # Dementia CHA2DS2-VASc score = 2 HASBLED score = 5 MRN: 00687089 (JYG)

CHEST X-Ray

Atrial fibrillation (53 bpm) EKG Atrial fibrillation (53 bpm)

Echocardiography LA 51 mm, LVEF 51 %

Saccular Aneurysm

Cardiac CT